News | June 17, 2023
USFDA completes inspection at Dr Reddy's Laboratories' Bollaram API unit
The inspection closed with zero observations
The inspection closed with zero observations
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
New Board of Directors and management team at Suven Pharma also appointed
This is the ninth Covid-19 vaccine approved in India
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The tablets are available in 150 mg and 225 mg strengths in bottle count sizes of 30 and 90.
Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
Subscribe To Our Newsletter & Stay Updated
